Determining the appropriate retatrutide amount is critically important for obtaining desired outcomes . Initially, patients typically commence with a modest dose of approximately 2.4 mg, provided each week via under the skin . This preliminary dose is then incrementally boosted every four instances , reaching a peak amount of 10.8 mg, depending on